palmidrol has been researched along with Abdominal Migraine in 4 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All patients had a diagnosis of migraine without aura (ICHD 3 criteria) and received umPEA (600 mg/day orally) for three months." | 2.94 | Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study. ( Alaimo di Loro, P; Ferilli, MAN; Moavero, R; Papetti, L; Sforza, G; Tarantino, S; Tullo, G; Ursitti, F; Valeriani, M; Vigevano, F, 2020) |
| "PEA nutraceuticals could be useful in migraine prevention." | 1.72 | Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine. ( Hernández, AG, 2022) |
| "Twenty-four subjects with episodic migraine (MIG) and 19 healthy controls (HC) underwent blood sampling and investigation of nociceptive withdrawal reflex thresholds (RTh: single-stimulus threshold; TST: temporal summation threshold) before and 30 (T30), 60 (T60), and 120 (T120) minutes after sublingual NTG administration (0." | 1.62 | Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks. ( Allena, M; De Icco, R; Demartini, C; Greco, R; Grillo, V; Realini, N; Reggiani, A; Sances, G; Tassorelli, C; Tumelero, E; Vergobbi, P; Zanaboni, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, AG | 1 |
| Papetti, L | 1 |
| Sforza, G | 1 |
| Tullo, G | 1 |
| Alaimo di Loro, P | 1 |
| Moavero, R | 1 |
| Ursitti, F | 1 |
| Ferilli, MAN | 1 |
| Tarantino, S | 1 |
| Vigevano, F | 1 |
| Valeriani, M | 1 |
| De Icco, R | 1 |
| Greco, R | 1 |
| Demartini, C | 1 |
| Vergobbi, P | 1 |
| Zanaboni, A | 1 |
| Tumelero, E | 1 |
| Reggiani, A | 1 |
| Realini, N | 1 |
| Sances, G | 1 |
| Grillo, V | 1 |
| Allena, M | 1 |
| Tassorelli, C | 1 |
| Sarchielli, P | 1 |
| Pini, LA | 1 |
| Coppola, F | 1 |
| Rossi, C | 1 |
| Baldi, A | 1 |
| Mancini, ML | 1 |
| Calabresi, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Factors Associated With Migraine Refractoriness to Preventive Treatments: Psychological Aspects and Relationship With Components of the Endocannabinoid System[NCT05046119] | 80 participants (Anticipated) | Observational | 2021-09-15 | Not yet recruiting | |||
| Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack: a Cross-over, Randomized Controlled Study[NCT05718310] | 22 participants (Anticipated) | Interventional | 2022-11-01 | Recruiting | |||
| Peripheral Gene Expression of Endocannabinoid System Components in Episodic and Chronic Migraine Patients: a Pilot Study[NCT04324710] | 75 participants (Actual) | Observational | 2017-12-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for palmidrol and Abdominal Migraine
| Article | Year |
|---|---|
Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.
Topics: Amides; Analgesics; Child; Ethanolamines; Female; Humans; Male; Migraine Disorders; Palmitic Acids; | 2020 |
3 other studies available for palmidrol and Abdominal Migraine
| Article | Year |
|---|---|
Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine.
Topics: Adult; Amides; Dietary Supplements; Double-Blind Method; Ethanolamines; Female; Humans; Male; Middle | 2022 |
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks.
Topics: Amides; Ethanolamines; Humans; Migraine Disorders; Nitroglycerin; Nociception; Palmitic Acids | 2021 |
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks.
Topics: Amides; Ethanolamines; Humans; Migraine Disorders; Nitroglycerin; Nociception; Palmitic Acids | 2021 |
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks.
Topics: Amides; Ethanolamines; Humans; Migraine Disorders; Nitroglycerin; Nociception; Palmitic Acids | 2021 |
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks.
Topics: Amides; Ethanolamines; Humans; Migraine Disorders; Nitroglycerin; Nociception; Palmitic Acids | 2021 |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Topics: Adult; Amides; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; | 2007 |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Topics: Adult; Amides; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; | 2007 |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Topics: Adult; Amides; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; | 2007 |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Topics: Adult; Amides; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; | 2007 |